Indefinite Delivery Contract SPE2D024D0002
Award Date
6/5/24
Last Date to Order
6/4/34
Federal Agency
Medical Supply Chain
Awardee
Prasco, LLC
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to Prasco, LLC, a for-profit limited liability company, on November 5, 2018. The contract, which has a potential value of $18,283,585.45, is for the manufacture and distribution of pharmaceutical products such as sodium fluoride dental gel and atovaquone/proguanil tablets. These products are provided to U.S. federal government agencies, including the Department of Veterans Affairs...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded Scpharmaceuticals Inc., a for-profit pharmaceutical company based in Lexington, MA, a Federal Supply Schedule (FSS) contract valued at $600,875.40. This multiple-award, indefinite-delivery, indefinite-quantity (IDIQ) contract, designated as FSS 65 IB, covers the provision of drugs, pharmaceuticals, and hematology-related products to VA facilities over a five-year period ending in November 2028. In...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor, for the procurement of Prasugrel HCL Tablets in 5mg and 10mg strengths. The contract has a base period of one year and four one-year option periods, with a total ceiling value of $2,445,241.70. This IDC will enable the VA, Department of Defense, Bureau of Prisons, Indian Health...
This Federal Supply Schedule contract awards Pacira Pharmaceuticals, Inc. as the prime contractor to provide the Department of Veterans Affairs (VA) with a range of drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB. The multiple-award, indefinite-delivery/indefinite-quantity (IDIQ) contract has a total potential value of $93,582,250 over the 5-year period of performance from September 2022 to August 2027. As the prime, Pacira Pharmaceuticals will deliver the contracted...
The U.S. Department of Veterans Affairs (VA) has awarded a $1.7M Federal Supply Schedule (FSS) contract to Amneal Pharmaceuticals of New York, LLC, a for-profit limited liability company that manufactures pharmaceutical products. The FSS contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, enables the VA to procure a variety of drugs, pharmaceuticals, and hematology-related products from Amneal through task orders over the 5-year contract period. Separately, the VA has also...
The Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract to UCB, Inc., a global biopharmaceutical company, for the procurement of pharmaceutical products under the Pharmaceuticals and Drugs FSS-61-IB contract. Under this contract, UCB, Inc. has been awarded multiple Firm Fixed Price delivery orders and Blanket Purchase Agreements (BPAs) to supply the VA with various drugs, including ZilbrysQ, Cimzia, Nayzilam, Neupro, Vimpat, Briviact, and Keppra. The delivery...
The Federal Supply Schedule contract awarded to Purdue Pharma LP by the Department of Veterans Affairs' Health Administration network provides a $243,488,600.00 multiple award indefinite delivery vehicle for pharmaceuticals and drugs under GSA Schedule 65 IB. The 5-year contract, which runs from May 2022 to April 2027, allows the VA's Veterans Integrated Service Network 12 to place task orders for a variety of prescription and over-the-counter medications commonly used in hospital and clinical...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA) to Apotex Corp., provides for the delivery of 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products. The contract has a ceiling value of $23,375,390.00 and a period of performance running from September 15, 2024 through September 14, 2029. As a Federal Supply Schedule (FSS) contract, this is a multiple award vehicle that allows federal agencies to procure the specified pharmaceutical and related...
The Department of Veterans Affairs awarded a Federal Supply Schedule contract to Vyera Pharmaceuticals, LLC to procure drugs, pharmaceuticals, and related hematology products. The potential value of this multiple award schedule is $3.5 million with an ordering period through September 2029. Additionally, the National Acquisition Center established a single award Blanket Purchase Agreement with Vyera Pharmaceuticals on behalf of the Veterans Health Administration. Valued at $450,000, this BPA...
The U.S. Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) worth up to $2,500,000 to Amneal Pharmaceuticals of New York, LLC, a for-profit limited liability company that manufactures pharmaceutical products. The BPA is for the provision of the generic drug sodium oxybate, which is used to treat narcolepsy. Amneal Pharmaceuticals holds several indefinite delivery vehicle (IDV) contracts with federal agencies, including a 5-year, $1,700,000 Federal Supply...